Hepion Pharmaceuticals Files Q1 2025 10-Q
Ticker: CTRVP · Form: 10-Q · Filed: May 19, 2025 · CIK: 1583771
| Field | Detail |
|---|---|
| Company | Hepion Pharmaceuticals, Inc. (CTRVP) |
| Form Type | 10-Q |
| Filed Date | May 19, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, pharmaceuticals, financials
TL;DR
Hepion Pharma's Q1 2025 10-Q is in. Check financials.
AI Summary
Hepion Pharmaceuticals, Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly ContraVir Pharmaceuticals, Inc., is based in Edison, NJ. The filing details financial information and business operations for the first quarter of 2025.
Why It Matters
This filing provides investors with the latest financial performance and operational updates for Hepion Pharmaceuticals, crucial for understanding the company's current standing and future prospects.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Hepion is subject to inherent risks related to drug development, regulatory approvals, and market competition.
Key Players & Entities
- Hepion Pharmaceuticals, Inc. (company) — Filer of the 10-Q
- ContraVir Pharmaceuticals, Inc. (company) — Former name of Hepion Pharmaceuticals
- 20250331 (date) — End of the reporting period
- 20250519 (date) — Filing date
- Edison, NJ (location) — Company's business address
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is the quarter ended March 31, 2025.
What was Hepion Pharmaceuticals' former company name?
Hepion Pharmaceuticals, Inc. was formerly known as ContraVir Pharmaceuticals, Inc.
Where is Hepion Pharmaceuticals, Inc. located?
Hepion Pharmaceuticals, Inc. is located at 399 Thornall Street, First Floor, Edison, NJ 08837.
When was this 10-Q form filed?
This 10-Q form was filed on May 19, 2025.
What is the Standard Industrial Classification (SIC) code for Hepion Pharmaceuticals?
The SIC code for Hepion Pharmaceuticals is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 19, 2025 regarding Hepion Pharmaceuticals, Inc. (CTRVP).